Metabolic pitfall of pseudoprogression after epcoritamab treatment

Metabolic pitfall of pseudoprogression after epcoritamab treatment

Saved in:

Bibliographic Details
Main Authors:	Osamu Imataki, Shumpei Uchida, Makiko Uemura
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	eJHaem
Subjects:	18F‐FDG‐PET epcoritamab malignant lymphoma pseudoprogression
Online Access:	https://doi.org/10.1002/jha2.1026
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
by: Mohanad Badarneh, et al.
Published: (2025-07-01)

18F-FDG PET/CT in the diagnosis and treatment of atypical extensive skin lesions in extranodal natural killer/T-cell lymphoma, nasal type: a case report
by: Xu-Sheng Liu, et al.
Published: (2025-04-01)

Predictive value of initial involvement and early response assessment using positron‑emission tomography with 18F‑FLT in patients with non‑Hodgkin lymphoma
by: Yu. N. Likar, et al.
Published: (2014-07-01)

DETECTION OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH LYMPHOMAS USING THE COMBINED PET-CT
by: А. V. Vazhenin, et al.
Published: (2016-02-01)

The role of 18F-FDG PET/CT in diagnosing cardiac infiltration and therapeutic evaluation in extranodal nasal-type NK/T-cell lymphoma: a case report
by: Taiping Liao, et al.
Published: (2025-03-01)

Prognostic value of a simple distance index derived from PET maximum intensity projection
by: Isaac Kargar Samani, et al.
Published: (2025-07-01)

THE DIAGNOSTIC ROLE OF 18F-FDG-PET/CT IN PATIENTS WITH CONSTITUTIONAL SYMPTOMS
by: Mustafa Altınkaynak, et al.
Published: (2023-03-01)

Can positron emission tomography with 18F-FDG substitute bone marrow biopsy for detecting bone marrow infiltration in patients with large B-cell lymphoma?
by: Susan Adil Ali, et al.
Published: (2025-07-01)

COMPARISON BETWEEN 18F-PSMA AND 18F-FDG RADIOTRACERS FOR PET/CT IN THE EVALUATION OF PATIENTS WITH METASTATIC MELANOMA
by: Thiago Soare Rocha Alves, et al.
Published: (2025-05-01)

Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
by: Chakrapani Balijepalli, et al.
Published: (2025-04-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
by: Shiqing Liu, et al.
Published: (2025-08-01)

18 F-FDG Positron Emission Tomography in Multifocal Pyomyositis
by: C. N. B. Harisankar, et al.
Published: (2012-01-01)

Oligodendroglioma pseudoprogression after radiotherapy in a dog: a case report
by: Nicholas Rancilio, et al.
Published: (2025-05-01)

FDG PET/CT AND PSMA PET/CT IN MUSCULOSKELETAL SOFT TISSUE SARCOMAS
by: Ellen Nogueira Lima, et al.
Published: (2025-05-01)

Case Report: Persistent COVID-19 in a fully vaccinated Japanese man being treated with rituximab and epcoritamab for diffuse large B-cell lymphoma
by: Masaki Suzuki, et al.
Published: (2025-04-01)

Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected
by: Fernanda Guerra Paiva, et al.
Published: (2019-02-01)

IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma
by: Shuaishuai Xu, et al.
Published: (2024-12-01)

Unexpected Rare Association of Secondary Breast, Thyroid, and Ovarian Lymphomas in a Female Patient with Burkitt Lymphoma: PET-CT Findings
by: Salah Nabih Ouriagli
Published: (2022-03-01)

An interpretable machine learning model for predicting bone marrow invasion in patients with lymphoma via 18F-FDG PET/CT: a multicenter study
by: Xinyu Zhu, et al.
Published: (2025-07-01)

[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
by: Dandan Yu, et al.
Published: (2025-01-01)

18F-FDG PET/CT Impact on Malignant Melanoma Patients Undergoing Staging and Restaging: A Single-University-Center Experience in a Real-World Setting
by: Silvija Lucic, et al.
Published: (2025-06-01)

18F-FDG PET/CT revealed primary malignant giant cell tumor of the sacrum: a case report
by: Zelong Feng, et al.
Published: (2025-08-01)

[18F]-FDG PET-CT in Malignant Melanoma
by: Teodora Sidonia Mititelu, et al.
Published: (2025-05-01)

EVALUATION OF 18F-PSMA PET/CT UPTAKE IN PATIENTS WITH GASTRIC ADENOCARCINOMA: AN EXPLORATORY ANALYSIS
by: Renata Erbert Contriciani, et al.
Published: (2025-05-01)

Distribution of metastases after radiotherapy in relation to radiation exposure fields: evaluation by 18F-FDG PET/CT
by: Jiucen Liang, et al.
Published: (2024-11-01)

Radiomics and Radiogenomics in Differentiating Progression, Pseudoprogression, and Radiation Necrosis in Gliomas
by: Sohil Reddy, et al.
Published: (2025-07-01)

18F-FDG PET/CT-assisted diagnosis of mediastinal poorly differentiated neuroendocrine lung cancer presenting with bone metastasis as the initial symptom
by: Lingyu Hou, et al.
Published: (2025-05-01)

Novel PET imaging biomarkers as predictors of postoperative recurrence in lung adenocarcinoma
by: Cheng Zheng, et al.
Published: (2025-05-01)

ACHADOS METABÓLICOS PÓS VACINAÇÃO PARA COVID-19 EM PET-CT COM 18F-FDG
by: Antonio Eduardo Santos Stroppa
Published: (2025-05-01)

Clinical value of combined 18F-FDG and 18F-P3BZA imaging in the diagnosis of melanoma
by: Rongchen An, et al.
Published: (2025-05-01)

[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications
by: A. V. Parnas, et al.
Published: (2021-06-01)

Case Report: 18F-FDG PET/CT revealed diffuse pancreatic metastasis in paranasal sinuses rhabdomyosarcoma after treatment improvement
by: Xianwen Hu, et al.
Published: (2025-05-01)

Enlarged piloid astrocytoma of the midbrain: recurrence or pseudoprogression? A clinical case
by: Yu. Yu. Trunin, et al.
Published: (2016-03-01)

SSB expression is associated with metabolic parameters of 18F-FDG PET/CT in lung adenocarcinoma and can improve diagnostic efficiency
by: Zi-Yue Liu, et al.
Published: (2024-11-01)

The landscape of T-cell engagers for the treatment of follicular lymphoma
by: Alfredo Rivas-Delgado, et al.
Published: (2024-12-01)

PAPEL DO PET/CT COM 18F- FDG NA AVALIAÇÃO DO COLANGIOCARCINOMA: UM ESTUDO RETROSPECTIVO
by: Marcelo Moreira da Silva, et al.
Published: (2025-05-01)

Clinico-pathological factors and [18F]FDG PET/CT metabolic parameters for prediction of progression-free survival in radioiodine refractory differentiated thyroid carcinoma
by: Nguyen Thi Phuong, et al.
Published: (2024-12-01)

The clinical benefits of [18F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [18F]FDG PET/CT
by: Donghe Chen, et al.
Published: (2025-07-01)

Research on the characteristics of 18F-FDG PET/CT in mantle cell lymphoma and the discrimination between cellular morphological variants
by: REN Yixuan, et al.
Published: (2024-12-01)

18F-FDG PET/CT metabolic parameter changes to assess vascular inflammatory response in patients with diffuse large B-cell lymphoma
by: Wenli Xie, et al.
Published: (2025-03-01)